World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
42664
World Ranking
7313
National Ranking
224

Overview

Jean-François Emile is affiliated with Versailles Saint-Quentin-en-Yvelines University in France. Their research primarily focuses on medicine, with significant contributions in subfields such as physiology, oncology, immunology, pathology and forensic medicine, and genetics.

The scientist's work encompasses several main topics, including:

  • Histiocytic Disorders and Treatments
  • Mast cells and histamine
  • Parvovirus B19 Infection Studies
  • Cancer Immunotherapy and Biomarkers
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Colorectal Cancer Treatments and Studies
  • Cancer Genomics and Diagnostics

Jean-François Emile has published extensively in notable journals. Frequent publication venues include:

  • Blood
  • La Revue de Médecine Interne
  • Journal of Clinical Oncology
  • Annals of the Rheumatic Diseases
  • Leukemia

Among recent papers are:

  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms, 2022, Leukemia
  • Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network, 2021, PLoS ONE
  • ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition, 2021, Blood
  • Histiocytosis, 2021, The Lancet
  • Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child, 2021, Nature Medicine

Jean-François Emile has collaborated frequently with other researchers. Notable co-authors include:

  • Julien Haroche
  • Fleur Cohen-Aubart
  • Zahir Amoura
  • Jean Donadieu
  • Jérôme Razanamahery

Best Publications

  • KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer

    Astrid Lièvre;Jean-Baptiste Bachet;Delphine Le Corre;Valérie Boige

  • KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

    Astrid Lièvre;Jean-Baptiste Bachet;Valérie Boige;Anne Cayre

  • Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

    Jean-François Emile;Oussama Abla;Sylvie Fraitag;Annacarin Horne

  • INTERFERON-GAMMA-RECEPTOR DEFICIENCY IN AN INFANT WITH FATAL BACILLE CALMETTE-GUERIN INFECTION

    Emmanuelle Jouanguy;Frédéric Altare;Salma Lamhamedi;Patrick Revy

  • Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency

    Frédéric Altare;Anne Durandy;David Lammas;Jean-François Emile

  • Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO

    Jean Yves Blay;Sylvie Bonvalot;Paolo Casali;Haesun Choi

  • Foamy Macrophages from Tuberculous Patients' Granulomas Constitute a Nutrient-Rich Reservoir for M. tuberculosis Persistence

    Pascale Peyron;Julien Vaubourgeix;Julien Vaubourgeix;Yannick Poquet;Yannick Poquet;Florence Levillain;Florence Levillain

  • Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

    Nicolas Mounier;Josette Briere;Christian Gisselbrecht;Jean-Francois Emile

  • A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection

    Emmanuelle Jouanguy;Salma Lamhamedi-Cherradi;David Lammas;Susan E. Dorman

  • High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

    Julien Haroche;Frédéric Charlotte;Laurent Arnaud;Andreas von Deimling

  • Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

    Julien Haroche;Fleur Cohen-Aubart;Jean-François Emile;Laurent Arnaud

  • Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society.

    M. Aricò;M. Girschikofsky;T. Généreau;C. Klersy

  • Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.

    Frédéric Peyrade;Fabrice Jardin;Catherine Thieblemont;Antoine Thyss

  • Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver.

    Daniel Azoulay;Denis Castaing;Jinane Krissat;Alloua Smail

  • Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease

    Oussama Abla;Eric Jacobsen;Jennifer Picarsic;Zdenka Krenova

  • Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients

    Karim Belhadj;Felix Reyes;Jean-Pierre Farcet;Herve Tilly

  • Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis.

    E Jouanguy;S Lamhamedi-Cherradi;F Altare;M C Fondanèche

  • Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms

    Eli L. Diamond;Benjamin H. Durham;Julien Haroche;Zhan Yao

  • Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

    Nicolas F. Delahaye;Sylvie Rusakiewicz;Sylvie Rusakiewicz;Isabelle Martins;Cédric Ménard;Cédric Ménard

  • Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects

    Christophe Borg;Magali Terme;Julien Taïeb;Cédric Ménard

Frequent Co-Authors

Jean Donadieu
Jean Donadieu University of Paris-Saclay
Frédéric Charlotte
Frédéric Charlotte Université Paris Cité
Pierre Laurent-Puig
Pierre Laurent-Puig Université Paris Cité
Zahir Amoura
Zahir Amoura Université Paris Cité
Julien Taieb
Julien Taieb Université Paris Cité
Jean-Laurent Casanova
Jean-Laurent Casanova The University of Texas Southwestern Medical Center
Olivier Bouché
Olivier Bouché CHU de Reims
Jean-Yves Blay
Jean-Yves Blay Claude Bernard University Lyon 1
Axel Le Cesne
Axel Le Cesne Institut Gustave Roussy
Thierry André
Thierry André Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the field of medicine in the USA opens up numerous online degree options and career pathways. Many students start by entering support roles that are vital for healthcare operations. For example, pursuing one of the best online medical billing and coding schools can lead to in-demand careers in healthcare administration and finance.

Nursing remains a top choice for those aiming directly at patient care. Some schools now offer programs where you can become an LPN or RN without standardized test requirements. Learn more about whether do you have to take a teas test for lpn and find flexible entry pathways into nursing.

Those interested in leadership roles may consider a degree in healthcare administration, which is ideal for managing hospitals, clinics, or public health organizations. Registered nurses looking to advance their qualifications can explore adn to fnp bridge programs to become family nurse practitioners and broaden their scope of practice.

Best Scientists Citing Jean-François Emile

Trending Scientists

Recently Published Articles